Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
European Journal of Heart Failure|June 29, 2021
Cardiac, renal, and metabolic effects of sodium-glucose co-transporter 2 inhibitors: a position paper from the European Society of Cardiology ad-hoc task force on sodium-glucose co-transporter 2 inhibitorsWilliam G Herrington, Gianluigi Savarese, Richard Haynes, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|January 10, 2021
Development and Internal Validation of a Risk Score to Detect Asymptomatic Carotid StenosisMichiel H F Poorthuis, Paul Sherliker, Dylan R Morris, et al.
Clinical Kidney Journal|September 9, 2020
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Kidney International|November 18, 2017
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammationBenjamin C Storey, Natalie Staplin, Richard Haynes, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 23, 2016
Effect of Processing Delay and Storage Conditions on Urine Albumin-to-Creatinine RatioWilliam Herrington, Nicola Illingworth, Natalie Staplin, et al.
Clinical Kidney Journal|December 8, 2018
The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY studyWilliam G Herrington, David Preiss, Richard Haynes, et al.
Kidney International|February 4, 2018
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapyBenjamin C Storey, Natalie Staplin, Charlie H Harper, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 15, 2014
The effect of lowering LDL cholesterol on vascular access patency: post hoc analysis of the Study of Heart and Renal ProtectionWilliam Herrington, Jonathan Emberson, Natalie Staplin, et al.
Clinical Kidney Journal|March 29, 2021
Accelerometer-measured physical activity and functional behaviours among people on dialysisKhizr A Nawab, Benjamin C Storey, Natalie Staplin, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 31, 2023
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization StudyKillian Donovan, William G Herrington, Guillaume Paré, et al.
Pageof 9